Oculis Holding AG (FRA:CR5) Interest Expense : €-0.08 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Oculis Holding AG's interest expense for the three months ended in Mar. 2024 was € -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Oculis Holding AG's Operating Income for the three months ended in Mar. 2024 was € -15.87 Mil. Oculis Holding AG's Interest Expense for the three months ended in Mar. 2024 was € -0.04 Mil. Oculis Holding AG did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oculis Holding AG Interest Expense Historical Data

The historical data trend for Oculis Holding AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Interest Expense Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-2.43

-4.92

-6.53

-1.39

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial							-1.29	-0.02	-0.01	-0.01	-0.04

Oculis Holding AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.08 Mil.

Oculis Holding AG (FRA:CR5) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Oculis Holding AG's Interest Expense for the three months ended in Mar. 2024 was €-0.04 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-15.87 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €0.43 Mil.

Oculis Holding AG's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Oculis Holding AG did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Oculis Holding AG (FRA:CR5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

OCS:USA OCS:Iceland

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (FRA:CR5) Headlines

No Headlines